| P50 | author | David F. Penson | Q55714844 |
| | Richard M Hoffman | Q56469292 |
| | George Luta | Q56958961 |
| P2093 | author name string | David Aaronson | |
| | Kimberly M Davis | |
| | Jun Shan | |
| | Stephen K Van Den Eeden | |
| | Kathryn L Taylor | |
| | Amethyst D Leimpeter | |
| | Tania Lobo | |
| P2860 | cites work | Decision aids for people facing health treatment or screening decisions | Q24200969 |
| | Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. | Q30366082 |
| | Comorbidity measures for use with administrative data | Q32144770 |
| | Time trends and local variation in primary treatment of localized prostate cancer | Q33710948 |
| | Are you SURE?: Assessing patient decisional conflict with a 4-item screening test. | Q34062656 |
| | Physician visits prior to treatment for clinically localized prostate cancer. | Q34610617 |
| | Guideline for the management of clinically localized prostate cancer: 2007 update. | Q34629234 |
| | Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis | Q35577609 |
| | Physicians' decision-making style and psychosocial outcomes among cancer survivors | Q36106013 |
| | Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer | Q36433781 |
| | Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions | Q36520523 |
| | Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml | Q36837061 |
| | Active surveillance for early-stage prostate cancer: review of the current literature | Q37096700 |
| | Decision making and quality of life in the treatment of cancer: a review. | Q37273366 |
| | Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context | Q37288832 |
| | Access to information sources and treatment considerations among men with local stage prostate cancer | Q37356222 |
| | Use of advanced treatment technologies among men at low risk of dying from prostate cancer. | Q37378693 |
| | Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial | Q37711882 |
| | Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate Cancer. | Q38330462 |
| | Systematic Review of Decision Aids for Newly Diagnosed Patients with Prostate Cancer Making Treatment Decisions | Q38521478 |
| | Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer | Q39758890 |
| | Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer | Q40011072 |
| | Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment | Q40610953 |
| | Information and decision-making preferences of men with prostate cancer | Q40970927 |
| | Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer | Q42265374 |
| | Patterns and correlates of prostate cancer treatment in older men. | Q44039406 |
| | Educating African American men about the prostate cancer screening dilemma: a randomized intervention | Q45296042 |
| | Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions. | Q45942807 |
| | Preliminary treatment considerations among men with newly diagnosed prostate cancer | Q46251917 |
| | Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. | Q46450956 |
| | Factors that influence patient enrollment in active surveillance for low-risk prostate cancer | Q46667265 |
| | Anxiety and distress during active surveillance for early prostate cancer. | Q49112186 |
| | Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. | Q50596897 |
| | Making decisions about treatment for localized prostate cancer. | Q51054410 |
| | The Control Preferences Scale. | Q64986716 |
| | National trends in the management of low and intermediate risk prostate cancer in the United States | Q87532220 |
| | Prostate cancer, version 2.2014 | Q87842508 |
| | 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option | Q87882408 |
| P921 | main subject | decision making | Q1331926 |
| P577 | publication date | 2017-06-13 | |
| P1433 | published in | Psycho-Oncology | Q2805644 |
| P1476 | title | Decision-making processes among men with low-risk prostate cancer: A survey study | |